Biotech is coming to Wales
A new biotech organisation is eschewing more established innovation centres for Cardiff. Why?
In 2010 Simon Ward, an associate director in the neuroscience division at the pharmaceutical firm Glaxo-Smith Kline (GSK), was fired, along with the rest of the division. At the time, the guillotining of neuroscience was part of a global move in big pharma to back away from brain research, deemed too difficult and risky. Determined to help fill that void, Dr Ward secured £14m ($19m) from the Wellcome Trust, a charity, the Medical Research Council and others to launch a new institute focused on turning discoveries in neuroscience into medicines. And so the Medicines Discovery Institute (MDI) began.
Explore more
This article appeared in the Britain section of the print edition under the headline “Enter the dragon”
The English Midlands is unjustly overlooked
Not least by its own inhabitants
The grooming-gangs scandal is a stain on the British state
It involved a toxic combination of victim-blaming and misguided political correctness
The rise of Nigel McFarage
Reform UK fractures the myth of progressive Scotland
MI6’s new “C” used to be “Q”. And is good with the gadgets
She’s the first female head of Britain’s spy service, too
Britain’s newest way of demoralising doctors
A lottery decides where they will work